Browsing: Infectious Disease

hpjc-0521.jpg
Health Policy Journal Club , Health Policy , Advocacy , Health Care Administration , COVID-19

Health Policy Journal Club: Visits Down; Danger Up

5/6/2021 Surudh Daaram , Cedric Dark, MD, MPH, FACEP
Emergency department volumes dropped precipitously during the COVID-19 pandemic. This isn't a good thing, as studies are now showing the alarming effects when patients delay or forego healthcare. As v
48-2 Military Match.png
COVID-19 , Match , Military Advising

Navigating the Military Match through COVID: A Perspective from Army Medical Students Vying for a Spot as an Emergency Medicine Resident in the Midst of a Global Pandemic

4/9/2021 2LT Ryan M. Hodgeman, MC USA , 2LT Molly Sturlis, MC USA
In a typical year, medical students commissioned in the United States Army, applying to match in emergency medicine, prepare to visit and interview at four programs spread across the country. This was
48-2 PPE Redistribution.png
COVID-19

Taking Action When the Tides Turn: Medical Student-Led PPE Redistribution During the COVID-19 Pandemic

4/9/2021 Hannah Day, MS
When COVID-19 disrupted their medical training, medical students around the nation sought ways to help, from forming childcare networks to organizing drives for personal protective equipment. This art
48-2 COVID Airway.png
COVID-19 , Airway , Critical Care , Ventilator Management

Management of the COVID-19 Airway

4/8/2021 Connor Greer, MD , Robert Razick , Joel Hamm, MD, FACEP
There are many perspectives available and early data to guide management of COVID-19 patients who present with respiratory failure. This article will review practice-altering data and the approach use
48-2 Septic Shoulder.jpeg
Infectious Disease , Orthopedics

Dirty Drugs: A Case Report of Septic Arthritis of the Shoulder Caused by P. aeruginosa

4/8/2021 Andrew Wylie, DO , Brandon Bleess, MD EMT-T, FACEP, FAAEM, FAEMS , Vivian Lau, DO, FACEP, FAAEM
While Methicillin-resistant Staphylococcus aureus (MRSA) is a well-known and feared cause of septic arthritis, P. aeruginosa needs to be considered by the emergency physician when caring for an IV dru
48-2 President Message.jpg
President's Message , Match , COVID-19

Class of 2022, We're Here for You

4/8/2021 RJ Sontag, MD
As the COVID-19 pandemic evolves in 2021, major EM groups have once again stepped up to provide a unified roadmap to the away rotation and eSLOE process. Class of 2022, your training may look differe
48-2 Kawasaki or MIS-C.png
COVID-19 , Pediatric EM , Cardiology

Kawasaki Disease or MIS-C?

4/8/2021 Blair Gaines, MD
Clinical knowledge regarding how the COVID-19 virus affects children is still evolving. Multisystem Inflammatory Syndrome in Children (MIS-C) can be approached in the same way as a Kawasaki-Like Hyper
CCA-HOT ICU.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure (The HOT-ICU Trial)

3/22/2021 Nicholas Huth , Jonathan Pickos, DO , Brian Sumner, MD
The ideal oxygenation goal in patients with acute respiratory failure in the ICU remains unclear. The HOT ICU trial seeks to provide insight.
CCA-Receptor Antagonists.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Interleukin-6 Antagonists in Critically Ill Patients with COVID-19

3/18/2021 Oswald Reid, Jr., MD , Brian Sumner, MD
While much is still left to be known about COVID-19, research has supported the theory that an excessive host inflammatory response is responsible for much of the morbidity and mortality seen by the d
CCA-Tocilizumab.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY)

3/18/2021 Taylor Miller, MD , Brian Sumner, MD
Originally designed for use in rheumatoid arthritis, tocilizumab is being considered as a potential therapeutic agent to treat COVID-19.